Prestige Consumer Healthcare (PBH) Return on Sales Growth (3y) (2013 - 2025)

Prestige Consumer Healthcare (PBH) Return on Sales Growth (3y) (2013 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROS Growth (3y) (Qtr)
1 Haleon 89.33 Bn 87.46 Bn - -
2 Teva Pharmaceutical Industries 35.86 Bn 32.12 Bn 1.97 Bn 0.00
3 Zoetis 32.54 Bn 30.60 Bn 1.62 Bn 0.00
4 Takeda Pharmaceutical 27.63 Bn 23.57 Bn 4.39 Bn -1.00
5 United Therapeutics 23.12 Bn 20.96 Bn 648.10 Mn 0.00
6 RedHill Biopharma 21.80 Bn 21.80 Bn - -
7 Viatris 20.26 Bn 18.46 Bn 1.16 Bn 0.00
8 Neurocrine Biosciences 17.79 Bn 16.47 Bn 800.70 Mn 0.00
9 Elanco Animal Health 12.65 Bn 12.22 Bn 785.00 Mn 0.00
10 Prestige Consumer Healthcare 2.44 Bn 2.37 Bn 157.37 Mn 0.00

Historic Data

Download Data
DateValue
Dec 31, 2025 0.00
Sep 30, 2025 0.00
Jun 30, 2025 0.00
Mar 31, 2025 0.00
Dec 31, 2024 0.00
Sep 30, 2024 0.00
Jun 30, 2024 0.00
Mar 31, 2024 0.00
Dec 31, 2023 0.00
Sep 30, 2023 0.00
Jun 30, 2023 0.00
Mar 31, 2023 -1.00
Dec 31, 2022 0.00
Sep 30, 2022 0.00
Jun 30, 2022 0.00
Mar 31, 2022 1.00
Dec 31, 2021 0.00
Sep 30, 2021 0.00
Jun 30, 2021 0.00
Mar 31, 2021 0.00